These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 8761187)
21. Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations. Kraus A; Caballero-Uribe C; Jakez J; Villa AR; Alarcón-Segovia D J Rheumatol; 1992 Oct; 19(10):1572-4. PubMed ID: 1464870 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of Raynaud's phenomenon in young Greek males. Tzilalis V; Panagiotopoulos N; Papatheodorou G; Rallis E; Kassimos D Clin Rheumatol; 2011 Jan; 30(1):57-9. PubMed ID: 21120563 [TBL] [Abstract][Full Text] [Related]
23. Use of biofeedback training in treatment of Raynaud's disease and phenomenon. Yocum DE; Hodes R; Sundstrom WR; Cleeland CS J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523 [TBL] [Abstract][Full Text] [Related]
24. Impact of global warming on Raynaud's phenomenon: a modelling study. Khouri C; Roustit M; Cracowski JL F1000Res; 2020; 9():829. PubMed ID: 34322228 [No Abstract] [Full Text] [Related]
25. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease. Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Nakamura Y; Shinozaki N; Hirasawa M; Kato R; Shiraishi K; Kida H; Usuda K; Ishikawa T Jpn Circ J; 2000 Apr; 64(4):239-42. PubMed ID: 10783043 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of Raynaud's phenomenon in general practice in the east of Spain. Román Ivorra JA; Gonzálvez Perales JL; Fernández Carballido C; Graña J; Torres MJ Clin Rheumatol; 2001; 20(2):88-90. PubMed ID: 11346237 [TBL] [Abstract][Full Text] [Related]
34. [Idiopathic and secondary Raynaud's phenomenon. A comparative psychosomatic approach]. Bayle O; Consoli SM; Baudin M; Vayssairat M; Fiessinger JN; Housset E Presse Med; 1990 Apr; 19(16):741-5. PubMed ID: 2140158 [TBL] [Abstract][Full Text] [Related]
35. [Capillaroscopy and Raynaud's phenomenon]. Carpentier P; Franco A J Mal Vasc; 1984; 9(1):23-8. PubMed ID: 6707531 [TBL] [Abstract][Full Text] [Related]
36. Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Kallenberg CG; Wouda AA; The TH Am J Med; 1980 Nov; 69(5):675-80. PubMed ID: 6969028 [TBL] [Abstract][Full Text] [Related]
37. Raynaud's phenomenon and hand function in patients with rheumatoid arthritis. Tansey RJ; Wragg EA; Herrick AL J Rheumatol; 2010 Jun; 37(6):1358-9. PubMed ID: 20516043 [No Abstract] [Full Text] [Related]
38. HLA-B27 in French patients with rheumatoid arthritis. Saraux A; Guedes C; Allain J; Valls I; Baron D; Youinou P; Le Goff P Scand J Rheumatol; 1997; 26(4):269-71. PubMed ID: 9310106 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of Raynaud's phenomenon. Bartelink ML; Wollersheim H; van de Lisdonk E; Spruijt R; van Weel C Neth J Med; 1992 Oct; 41(3-4):149-52. PubMed ID: 1470286 [TBL] [Abstract][Full Text] [Related]
40. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study. Navon P; Yarom A; Davis E J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]